Luis Paz-Ares
MD PhD
Chief, Medical Oncology
👥Biography 个人简介
Luis Paz-Ares at H. 12 de Octubre has been one of the most influential European lung cancer oncologists, leading KEYNOTE-407 establishing pembrolizumab plus chemotherapy as standard first-line treatment for squamous cell NSCLC. He has contributed to multiple landmark immunotherapy trials across lung cancer histologies and has been influential in ESMO thoracic oncology guideline development.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Luis Paz-Ares 的研究动态
Follow Luis Paz-Ares's research updates
留下邮箱，当我们发布与 Luis Paz-Ares（Hospital 12 de Octubre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment